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Abstract 
Certain patients with disorders of sex development (DSD), who bear Y chromosome 
material in their karyotype, are at increased risk for the development of type II germ cell 
tumors (GCT), which arise from early fetal germ cells. DSD gonads frequently harbor 
immature germ cells which express early fetal germ cell markers. Some of them (e.g. 
OCT3/4 and NANOG) seem to be of pathogenetic relevance in GCT development 
providing cells with the ability of pluripotency,proliferation and apoptosis suppression. 
Also TSPY (testisspecific protein Y-encoded), the main candidate for the socalled 
gonadoblastoma locus on Y chromosome, is overexpressed in germ cells of DSD 
patients and possibly contributes to their survival and proliferation. Nowadays, the use 
of immunohistochemical methods is highly relevant in identifying DSD gonads at risk. 
The risk for GCT development varies. While the prevalence of GCT is 15% in patients 
with partial androgen insensitivity, it may reach more than 30% in patients with gonadal 
dysgenesis. Patients with complete androgen insensitivity and ovotesticular DSD 
develop ma lignancies in 0.8% and 2.6% of cases, respectively. However,these data 
may be biased for various reasons. To better estimate the risk in individual groups of 
DSD, further investigations on large patient series are needed. 
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